Skip to main content

Diigo Home

Financial Express : 'Stringent IP enforcement will limit access to generic dru... - The Diigo Meta page

www.financialexpress.com/...507036 - Annotated View

gibreel ferishta's personal annotations on this page

gibreel
Gibreel bookmarked on 2009-08-27 pharma drugs ip
  • ivil society organisations, led by Centre for Trade and Development, have sent a strong missive to the Confederation of Indian Industry (CII), urging it to be careful about associating with multinational corporations and developed countries that are keen to push more stringent intellectual property (IP) enforcement laws in India . The letter is in response to an international conference recently hosted by CII to enhance IP standards and their enforcement.

    Stressing that stricter IP enforcement laws will limit the access of life-saving generic drugs to people in developing countries, the letter asks CII to “not view IP as only a business tool” but also look at the larger scheme of things, given India’s social and economic realities.

    The letter also pointed to the controversial seizure of generic drugs shipped from India to Africa by customs authorities in the European Union. Though the drugs were not patent-protected in India or the consignee countries, EU authorities seized them in transit, arguing that the rights of patent-holders in Europe were being infringed. Freedom of transit for legitimate trade is clearly laid down under GATT. The Trade-Related Aspects of Intellectual Property (TRIPS) Agreement also emphasises that measures to protect intellectual property shoul

This link has been bookmarked by 1 people . It was first bookmarked on 27 Aug 2009, by gibreel ferishta.

  • 27 Aug 09
    • ivil society organisations, led by Centre for Trade and Development, have sent a strong missive to the Confederation of Indian Industry (CII), urging it to be careful about associating with multinational corporations and developed countries that are keen to push more stringent intellectual property (IP) enforcement laws in India . The letter is in response to an international conference recently hosted by CII to enhance IP standards and their enforcement.

      Stressing that stricter IP enforcement laws will limit the access of life-saving generic drugs to people in developing countries, the letter asks CII to “not view IP as only a business tool” but also look at the larger scheme of things, given India’s social and economic realities.

      The letter also pointed to the controversial seizure of generic drugs shipped from India to Africa by customs authorities in the European Union. Though the drugs were not patent-protected in India or the consignee countries, EU authorities seized them in transit, arguing that the rights of patent-holders in Europe were being infringed. Freedom of transit for legitimate trade is clearly laid down under GATT. The Trade-Related Aspects of Intellectual Property (TRIPS) Agreement also emphasises that measures to protect intellectual property shoul